Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition that makes breathing increasingly difficult over time. It includes conditions such as emphysema and chronic bronchitis, and is characterized by persistent cough, shortness of breath, wheezing, and frequent respiratory infections. COPD can significantly impact daily activities, limiting physical activity, sleep quality, and overall quality of life.

While COPD cannot be fully cured, ongoing clinical research and FDA-approved therapies aim to manage symptoms, improve lung function, and reduce flare-ups. Participating in clinical studies may give eligible individuals access to cutting-edge treatments at no cost, while contributing to advancements that help improve outcomes for people living with COPD.